Work

Impact of Ribavirin Dose Reductions in Hepatitis C Virus Genotype 1 Patients Completing Peginterferon Alfa-2a/Ribavirin Treatment

Year: 2006

Type: article

Source: Clinical Gastroenterology and Hepatology

DOI: 10.1016/j.cgh.2006.10.008

Authors: K. Rajender Reddy, Mitchell L. Shiffman, Timothy R. Morgan, Stefan Zeuzem, Stephanos Hadziyannis, Fayez M. Hamzeh, Teresa L. Wright, Michael Fried

Institutions: University of Pennsylvania, Virginia Commonwealth University, VA Long Beach Healthcare System, Universitätsklinikum des Saarlandes, Henry Dunant Hospital, University of North Carolina at Chapel Hill

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: University of Pennsylvania

OpenAlex ID: W2092005960

FWCI: 16.09

Cites: 19

Cited by: 191

Related to: 10